Postacute Care Services Use and Outcomes Among Traditional Medicare and Medicare Advantage Beneficiaries [0.03%]
传统医疗保险和Medicare优势受益人接受亚急性护理服务的使用情况及结果分析
Emma M Achola,David G Stevenson,Laura M Keohane
Emma M Achola
Importance: Better evidence is needed on whether Medicare Advantage (MA) plans can control the use of postacute care services while achieving excellent outcomes. ...
Natalie C Ernecoff,Rebecca Anhang Price
Natalie C Ernecoff
Importance: Hospice care is a unique type of medical care for people near the end of life and their families, with an emphasis on providing physical and psychological symptom management, spiritual care, and family caregiv...
Sherry Glied,Thomas D&#x;Aunno
Sherry Glied
Associations Between Ending Supplemental Nutrition Assistance Program Emergency Allotments and Food Insufficiency [0.03%]
关于营养补充援助计划应急津贴终止与食物不足关系的研究
Aaron Richterman,Christina A Roberto,Harsha Thirumurthy
Aaron Richterman
Eric Rubenstein,Amy Michals,Na Wang et al.
Eric Rubenstein et al.
Importance: Down syndrome is the leading genetic cause of intellectual disability and automatically qualifies individuals for Social Security Insurance. Therefore, Medicaid is the major health insurance provider for a pop...
Changes in Medicaid Fee-for-Service Benefit Design for Substance Use Disorder Treatment During the Opioid Crisis, 2014 to 2021 [0.03%]
2014至2021年美国医疗补助计划中的 substance use disorder治疗的按服务付费福利设计变化：阿片类药物危机期间
Angela Shoulders,Christina M Andrews,Melissa A Westlake et al.
Angela Shoulders et al.
Importance: Medicaid is the largest payer of substance use disorder treatment in the US and plays a key role in responding to the opioid epidemic. However, as recently as 2017, many state Medicaid programs still did not c...
FDA's 2023 Policy Update-Promoting Safety and Inclusivity in Blood Donation [0.03%]
美国食品药品监督管理局(FDA)2023年政策更新——促进献血安全性和包容性
Amitai S Miller,Sean Cahill,Kenneth H Mayer
Amitai S Miller
Food Is Medicine Movement-Key Actions Inside and Outside the Government [0.03%]
食物即是药物行动方案——政府内外的关键举措
Sara N Bleich,Roxanne Dupuis,Hilary K Seligman
Sara N Bleich
Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022 [0.03%]
2009至2022年零售药店340B药物定价计划合同增长趋势
Sayeh Nikpay,Claire C McGlave,John P Bruno et al.
Sayeh Nikpay et al.
Time From Authorization by the US Food and Drug Administration to Medicare Coverage for Novel Technologies [0.03%]
美国食品药品监督管理局授权至 medicare 新技术纳入报销的时间间隔分析：1984—2013年
Zachary A Sexton,Juliana R Perl,Henry R Saul et al.
Zachary A Sexton et al.
Importance: A wide variety of novel medical diagnostics and devices are determined safe and effective by the US Food and Drug Administration (FDA) each year, but to our knowledge the literature lacks evidence documenting ...